|Bid||0.0000 x 900|
|Ask||0.0000 x 2900|
|Day's range||4.0200 - 4.1700|
|52-week range||1.0100 - 4.3600|
|Beta (5Y monthly)||-0.49|
|PE ratio (TTM)||N/A|
|Earnings date||27 Mar 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||6.38|
Here is how Augmedix, Inc. (AUGX) and Boston Scientific (BSX) have performed compared to their sector so far this year.
Augmedix, Inc. (AUGX) delivered earnings and revenue surprises of 6.67% and 2.70%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?